Hosking Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58M | Sell |
150,011
-2,429
| -2% | -$901K | 1.93% | 13 |
|
|
2026
Q1 | $44.6M | Buy |
152,440
+7,892
| +5% | +$2.59M | 1.6% | 25 |
|
|
2025
Q4 | $50.7M | Buy |
144,548
+2,166
| +2% | +$732K | 1.72% | 19 |
|
|
2025
Q3 | $46M | Buy |
142,382
+65,307
| +85% | +$20.3M | 1.67% | 18 |
|
|
2025
Q2 | $30M | Sell |
77,075
-476
| -0.6% | -$191K | 1.19% | 22 |
|
|
2025
Q1 | $33.7M | Sell |
77,551
-686
| -0.9% | -$275K | 1.42% | 21 |
|
|
2024
Q4 | $28.9M | Sell |
78,237
-10,018
| -11% | -$4.19M | 1.13% | 32 |
|
|
2024
Q3 | $45.9M | Sell |
88,255
-15,233
| -15% | -$8.14M | 1.77% | 16 |
|
|
2024
Q2 | $56.1M | Sell |
103,488
-8,926
| -8% | -$4.72M | 2.08% | 12 |
|
|
2024
Q1 | $58.3M | Sell |
112,414
-338
| -0.3% | -$168K | 2.15% | 14 |
|
|
2023
Q4 | $53.2M | Sell |
112,752
-7,985
| -7% | -$3.69M | 2.24% | 10 |
|
|
2023
Q3 | $52.6M | Buy |
120,737
+20,267
| +20% | +$9.19M | 2.33% | 9 |
|
|
2023
Q2 | $44.6M | Buy |
100,470
+9,039
| +10% | +$4.17M | 1.89% | 13 |
|
|
2023
Q1 | $42M | Sell |
91,431
-18,492
| -17% | -$8.8M | 1.95% | 15 |
|
|
2022
Q4 | $56.4M | Buy |
109,923
+53,695
| +95% | +$27.3M | 2.28% | 9 |
|
|
2022
Q3 | $25.5M | Sell |
56,228
-3,522
| -6% | -$1.69M | 1.11% | 23 |
|
|
2022
Q2 | $28.8M | Sell |
59,750
-11,457
| -16% | -$5.67M | 1.14% | 24 |
|
|
2022
Q1 | $35M | Sell |
71,207
-1,627
| -2% | -$744K | 0.9% | 30 |
|
|
2021
Q4 | $33.8M | Sell |
72,834
-1,381
| -2% | -$581K | 0.82% | 35 |
|
|
2021
Q3 | $27.7M | Sell |
74,215
-8,303
| -10% | -$3.16M | 0.69% | 40 |
|
|
2021
Q2 | $31.5M | Sell |
82,518
-1,136
| -1% | -$434K | 0.7% | 37 |
|
|
2021
Q1 | $30M | Sell |
83,654
-3,194
| -4% | -$1.03M | 0.71% | 36 |
|
|
2020
Q4 | $27.9M | Sell |
86,848
-3,069
| -3% | -$942K | 0.72% | 35 |
|
|
2020
Q3 | $24.2M | Sell |
89,917
-3,051
| -3% | -$821K | 0.74% | 34 |
|
|
2020
Q2 | $24.4M | Sell |
92,968
-6,768
| -7% | -$1.81M | 0.75% | 34 |
|
|
2020
Q1 | $22.6M | Sell |
99,736
-3,246
| -3% | -$885K | 0.79% | 34 |
|
|
2019
Q4 | $31.1M | Sell |
102,982
-3,988
| -4% | -$1.1M | 0.76% | 38 |
|
|
2019
Q3 | $25.7M | Sell |
106,970
-5,269
| -5% | -$1.44M | 0.67% | 42 |
|
|
2019
Q2 | $31.7M | Sell |
112,239
-769
| -0.7% | -$210K | 0.77% | 36 |
|
|
2019
Q1 | $32.4M | Sell |
113,008
-578
| -0.5% | -$167K | 0.82% | 36 |
|
|
2018
Q4 | $29.8M | Buy |
113,586
+11,494
| +11% | +$3.16M | 0.85% | 37 |
|
|
2018
Q3 | $28M | Sell |
102,092
-2,972
| -3% | -$772K | 0.62% | 44 |
|
|
2018
Q2 | $25M | Sell |
105,064
-20,040
| -16% | -$4.64M | 0.55% | 54 |
|
|
2018
Q1 | $27.5M | Buy |
125,104
+5,486
| +5% | +$1.29M | 0.61% | 48 |
|
|
2017
Q4 | $26.9M | Buy |
119,618
+8,278
| +7% | +$1.76M | 0.62% | 45 |
|
|
2017
Q3 | $21.1M | Buy |
111,340
+327
| +0.3% | +$62.2K | 0.55% | 50 |
|
|
2017
Q2 | $20.9M | Buy |
111,013
+1,795
| +2% | +$323K | 0.55% | 49 |
|
|
2017
Q1 | $18.1M | Buy |
109,218
+9,858
| +10% | +$1.57M | 0.5% | 54 |
|
|
2016
Q4 | $14.3M | Sell |
99,360
-2,569
| -3% | -$344K | 0.46% | 56 |
|
|
2016
Q3 | $12.8M | Buy |
101,929
+12,334
| +14% | +$1.59M | 0.43% | 64 |
|
|
2016
Q2 | $11.8M | Buy |
89,595
+23,100
| +35% | +$3.16M | 0.49% | 60 |
|
|
2016
Q1 | $9.24M | Buy |
66,495
+4,937
| +8% | +$660K | 0.42% | 66 |
|
|
2015
Q4 | $8.58M | Buy |
61,558
+801
| +1% | +$110K | 0.4% | 70 |
|
|
2015
Q3 | $8.51M | Buy |
+60,757
| New | +$9.13M | 0.41% | 65 |
|
Other funds holding ELV
Hosking Partners's ELV Position: Q2 2026 in Review
Hosking Partners reduced its Elevance Health (ELV) stake by 1.6% in Q2 2026, selling an estimated $901K and leaving 150,011 shares worth $58M. The position accounts for 1.93% of the portfolio, ranked #13.
Hosking Partners first reported a position in ELV in Q3 2015 and has held it in 44 quarters since. The position peaked at $58.3M in Q1 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Hosking Partners held 150,011 shares of Elevance Health worth $58M as of Q2 2026.
- Hosking Partners sold 2,429 Elevance Health shares in Q2 2026, an estimated $901K.
- Elevance Health made up 1.93% of Hosking Partners's portfolio in Q2 2026, its #13 holding.
- Hosking Partners first reported a position in Elevance Health in Q3 2015 and has held it in 44 quarters since.
- Hosking Partners's Elevance Health position peaked at $58.3M in Q1 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Hosking Partners's 13F filing for Q2 2026, filed 3 Aug 2026.